LINC02294

Across TCGA pan-cancer cohorts, LINC02294 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC02294 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02294 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02294 expression acts as an unfavorable survival marker, although some lineages such as KIRC and KIRP show a favorable association.

LIHC, KIRC, and BRCA are the cancer types where LINC02294 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.254	0.463	<.001	90	view →
KIRC	DFS	Median	All	0.720	0.539	<.001	64	view →
BRCA	OS	Tertile	All	0.395	0.602	.001	54	view →
KIRP	OS	Tertile	II,III,IV	1.000	0.260	<.001	51	view →
THYM	DFS	Tertile	All	0.660	0.920	.002	30	view →
STAD	DFS	Tertile	II,III,IV	0.463	0.563	.019	29	view →
LUAD	OS	Tertile	All	0.755	0.857	.011	27	view →
LGG	OS	Tertile	All	0.945	0.812	<.001	24	view →
READ	DFS	Tertile	All	0.630	0.885	.011	21	view →
SARC	OS	Tertile	All	0.235	0.611	.012	21	view →
CHOL	OS	Tertile	All	0.114	0.623	.033	9	view →
HNSC	DFS	Tertile	III,IV	0.225	0.512	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC02294–LIHC (DFS)

Open the LIHC breakdown →